Applicant, as named in the Orange Book

Harm Reduction Therp

Next listed expiry: Rivive on 11 May 2032. 1 products with live protection, 0 without.

Products with listed protection

Drug	Ingredient	NDA	Earliest generic entry	Basis
Rivive naloxone hydrochloride	naloxone hydrochloride	217722	11 May 2032	patent

No events yet. The first ingestion only records products entering their 12-month window; changes appear from the next Orange Book update.